Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bmy 40481-30
2. Bmy-40481
3. Bmy-40481-30
4. Etophos
5. Etopofos
6. Etopophos
1. 117091-64-2
2. Etopofos
3. Etopophos
4. Etopophos Preservative Free
5. Bmy 40481
6. Vepeside
7. Etoposide Phosphate [usan]
8. Bmy-40481
9. 528xyj8l1n
10. Vp16
11. Etophos
12. Etoposide Phosphate (usan)
13. Etoposide 4'-phosphate
14. Unii-528xyj8l1n
15. Etoposide-phosphate
16. Etopophos (tn)
17. Ncgc00185753-01
18. Eposin Etopophos Vepesid Vp16
19. Etoposide Phosphate (etopophos)
20. Chembl1200645
21. Etoposide Phosphate [mi]
22. Schembl13318053
23. Chebi:135867
24. Etoposide Phosphate [vandf]
25. Etoposide Phosphate [mart.]
26. Ex-a3595
27. Zinc3920020
28. Bdbm50247889
29. Etoposide Phosphate [usp-rs]
30. Etoposide Phosphate [who-dd]
31. Mfcd00270859
32. Akos025311200
33. Etoposide Phosphate [orange Book]
34. Ncgc00185753-04
35. 4'-demethylepipodophyllotoxin 9-(4,6-o-(r)-ethylidene-beta-d-glucopyranoside), 4'-(dihydrogen Phosphate)
36. As-12896
37. Hy-13630
38. Etoposide Phosphate [usp Monograph]
39. Cs-0007496
40. D04107
41. 091e642
42. J-003505
43. Q27260984
44. [4-[(5s,5ar,8ar,9r)-5-[[(2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-8-oxo-5a,6,8a,9-tetrahydro-5h-[2]benzofuro[5,6-f][1,3]benzodioxol-9-yl]-2
45. 4'-demethylepipodophyllotoxin 9-(4,6-o-(r)-ethylidene-.beta.-d-glucopyranoside), 4'-(dihydrogen Phosphate)
46. Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, 5-(3,5-dimethoxy-4-(phosphonooxy)phenyl)-9-((4,6-o-ethylidene-.beta.-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-, (5r-(5.alpha.,5a.beta.,8a.alpha.,9.beta.(r*)))-
47. Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, 5-(3,5-dimethoxy-4-(phosphonooxy)phenyl)-9-((4,6-o-ethylidene-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-, (5r-(5alpha,5abeta,8aalpha,9beta(r*)))-
Molecular Weight | 668.5 g/mol |
---|---|
Molecular Formula | C29H33O16P |
XLogP3 | -0.7 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 7 |
Exact Mass | 668.15062196 g/mol |
Monoisotopic Mass | 668.15062196 g/mol |
Topological Polar Surface Area | 207 Ų |
Heavy Atom Count | 46 |
Formal Charge | 0 |
Complexity | 1140 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10476
Submission : 1993-09-17
Status : Active
Type : II
Related Excipient Companies
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?